Abstract

P2X receptors comprise a family of ATP-gated ion channels with the basic amino acids Lys-68, Arg-292, and Lys-309 (P2X(1) receptor numbering) contributing to agonist potency. In many ATP-binding proteins aromatic amino acids coordinate the binding of the adenine group. There are 20 conserved aromatic amino acids in the extracellular ligand binding loop of at least 6 of the 7 P2X receptors. We used alanine replacement mutagenesis to determine the effects of individual conserved aromatic residues on the properties of human P2X(1) receptors expressed in Xenopus oocytes. ATP evoked concentration-dependent (EC(50) approximately 1 microm) desensitizing currents at wild-type receptors and for the majority of mutants there was no change (10 residues) or a <6-fold decrease in ATP potency (6 mutants). Mutants F195A and W259A failed to form detectable channels at the cell surface. F185A and F291A produced 10- and 160-fold decreases in ATP potency. The partial agonists 2',3'-O-(4-benzoyl)-ATP (BzATP) and P(1),P(5)-di(adenosine 5')-pentaphosphate (Ap(5)A) were tested on a range of mutants that decreased ATP potency to determine whether this resulted predominantly from changes in agonist binding or gating of the channel. At K68A and K309A receptors BzATP and Ap(5)A had essentially no agonist activity but antagonized, or for R292A potentiated, ATP responses. At F185A receptors BzATP was an antagonist but Ap(5)A no longer showed affinity for the receptor. These results suggest that residues Lys-68, Phe-185, Phe-291, Arg-292, and Lys-309 contribute to ligand binding at P2X(1) receptors, with Phe-185 and Phe-291 coordinating the binding of the adenine ring of ATP.

Highlights

  • BzATP EC50 was calculated for those mutants where BzATP was an effective agonist (n ϭ 3–5)

  • A, F185A, F291A, R292A (100 ␮M ATP) and K68A and K309A (3 mM ATP) all show a reduced response to ATP in the presence of 100 ␮M BzATP compared with P2X1 wild-type (WT) receptors (100 ␮M ATP) (n ϭ 3)

  • In the present study we have shown that for the P2X1 receptor mutants with a decrease in ATP potency (K68A, F185A, F291A, R292A, and K309A) the activity of the partial agonist BzATP was essentially abolished, BzATP still binds to the channel and acts as an antagonist

Read more

Summary

Introduction

For mutants F198A, F293A, Y55A, K70A, and C217A with less than a 10-fold decrease in ATP potency the point mutations had no, or less than a 2-fold effect on the partial agonist activity of BzATP (Fig. 5C) suggesting that these residues do not make a major contribution to agonist binding to the P2X1 receptor.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call